Skip to content

The Role of Melanocyte in Basal Cell Carcinoma

Melanocyte Features and Its Influence in Pigmentation in Basal Cell Carcinoma in the Mexican Population

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02576769
Enrollment
30
Registered
2015-10-15
Start date
2015-11-30
Completion date
2016-12-31
Last updated
2015-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma

Keywords

Basal cell carcinoma, Pigmentation, Melanocyte, Melanin, Skin cancer

Brief summary

Basal cell carcinoma (BCC) is the most frequent neoplasia worldwide. There are more than 30 histopathologic subtypes, however the nodular subtype is the most common. Pigmented varieties are common in darker skin types, therefore in our country. Previous studies have shown an increase number and size of melanocytes. Melanogenesis were increased at the expense of hyperfunctioning melanocytes as well. The aim of the study was to describe the characteristics of melanocytes in pigmented and non-pigmented variants of basal cell carcinoma.

Detailed description

Melanocytes are highly specialized dendritic cells that performs multiple functions through autocrine, paracrine and endocrine mechanisms. These cells are part of a complex system of intercellular communication along with keratinocytes, Langerhans cells and fibroblasts. This intricate network of cellular communication is possible thanks to interaction with cytokines, growth factors and neurotransmitters. Although melanocytes perform brilliantly immunoregulatory and neuroendocrine functions, their fundamental role is to offer protection against the harmful effects of UV radiation through production and transference of melanin to keratinocytes, a process better known as melanogenesis. The latter requires 3 basic proteins to ensure photoprotection: MC1R (activation), MITF (traduction) and TYR (melanin synthesis). If one of the main features of melanocytes is to avoid UV radiation injurious effect, thus it raises many questions regarding the possible relation between these cells and skin cancer. Currently a great number of melanocytic alterations have been described in melanoma; however in non-melanoma skin cancer the role of melanocytes is less clear. Basal cell carcinoma (BCC) is the most frequent neoplasia worldwide. There are more than 30 histopathologic subtypes, however the nodular subtype is the most common. Pigmented varieties are common in darker skin types, therefore in our country. Previous studies have shown an increase number and size of melanocytes. Melanogenesis were increased at the expense of hyperfunctioning melanocytes as well. In our experience we have noticed the clinical course regarding pigmented nodular basal cell carcinoma is more benign when compared to those without pigment. Most studies regarding the role of melanocytes and pigmentation in basal cell carcinoma have been conducted in caucasian populations, and therefore not representative of what may occur in mestizo population. The aim of the study was to describe the characteristics of melanocytes in pigmented and non-pigmented variants of basal cell carcinoma. Quantify the expression of melanocytic maturation: transcription factors (SOX9 and SOX10), focal adhesion kinase (FAK125) and receptor tyrosine kinase (c-KIT) and melanogenesis such as melanocortin 1 receptor (MC1R), microphthalmia-associated transcription factor (MITF) and tyrosinase (TYR) markers. Investigate the tumoral microenvironment through the quantification of melanin, mast cells, angiogenesis and solar elastosis.

Interventions

OTHERNo intervention

Sponsors

Hospital Central Dr. Ignacio Morones Prieto
CollaboratorOTHER
Universidad Autonoma de San Luis Potosí
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Mexican subjects * Age between 40 and 90 years * Both genders * Sign informed consent

Exclusion criteria

* Sign informed consent withdrawal

Design outcomes

Primary

MeasureTime frameDescription
Melanocyte numberUp to 1 yearTo quantify the number of melanocytes in basal cell carcinoma
Melanocyte phenotypeUp to 1 yearTo quantify melanocyte maturation stages in basal cell carcinoma through markers
Melanogenesis characteristicsUp to 1 yearTo quantify the expression of melanogenic markers in basal cell carcinoma

Secondary

MeasureTime frameDescription
Melanin presenceUp to 1 yearTo quantify melanin deposition in basal cell carcinoma using special histologic stains (Fontana-Masson)
Solar elastosis quantityUp to 1 yearTo quantify solar elastosis in basal cell carcinoma using special histologic stains (Elastic fibers)
Vessels number (angiogenesis)Up to 1 yearTo quantify number of vessels in basal cell carcinoma using special histologic stains (Elastic fibers)
Mast cells numberUp to 1 yearTo quantify melanocytes in basal cell carcinoma using special histologic stains (Giemsa)

Countries

Mexico

Contacts

Primary ContactJuan P Castanedo-Cazares, MD, MSc
castanju@yahoo.com4448342795
Backup ContactBertha Bertha Torres-Alvarez, MD
torresmab@yahoo.com.mx4448342795

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026